Home › Funds › LMCG INVESTMENTS, LLC › REGN

LMCG INVESTMENTS, LLC position in REGN

REGENERON PHARMACEUTICALS · Health Care

LMCG INVESTMENTS, LLC reported holding 37,703 shares of REGN (REGENERON PHARMACEUTICALS) in its Q3 2026 13F filing — a position valued at US$28.6M, representing 1.54% of its reported portfolio and ranking #11 among its reported holdings. LMCG INVESTMENTS, LLC has disclosed REGN holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)37.70K sh
Reported value held$28.59M
Portfolio Weight1.54%
First reportedQ3 2023
Last changeAdd
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How LMCG INVESTMENTS, LLC's REGN position evolved

LMCG INVESTMENTS, LLC first disclosed a stake in REGN in Q3 2023 at 4,646 shares (US$3.8M). The position peaked in Q4 2025 at 39,821 shares, worth US$30.7M. Across 13 filings, LMCG INVESTMENTS, LLC increased the stake 6 time(s), trimmed it 3 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 37,703 shares valued at US$28.6M — an increase of 866 shares quarter over quarter.. Notable position changes include a 231% increase in Q1 2025 (shares fell 17% over the following quarter), a 132% increase in Q2 2025 (shares rose 8% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 4.65K $3.82M New
Q4 2023 4.63K $4.07M Hold
Q1 2024 4.62K $4.44M Hold
Q2 2024 4.83K $5.08M Add
Q3 2024 4.82K $5.07M Hold
Q4 2024 4.37K $3.11M Reduce
Q1 2025 14.48K $9.18M Add
Q2 2025 33.60K $17.64M Add
Q3 2025 36.27K $20.39M Add
Q4 2025 39.82K $30.74M Add
Q1 2026 38.98K $30.12M Reduce
Q2 2026 36.84K $22.97M Reduce
Q3 2026 37.70K $28.59M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About REGN and 13F data

REGN (REGENERON PHARMACEUTICALS) is a Health Care company. 29 other funds we track also report a position in REGN — the largest reported positions include Dodge & Cox (US$3.04B), DODGE & COX (US$3.04B), Franklin Resources (US$2.75B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding REGN

All REGN fund holders →

FAQ

How long has LMCG INVESTMENTS, LLC held REGN?

LMCG INVESTMENTS, LLC has disclosed REGN holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is LMCG INVESTMENTS, LLC's current position in REGN?

As of Q3 2026, LMCG INVESTMENTS, LLC holds 37.70K shares of REGN (REGENERON PHARMACEUTICALS), valued at $28.59M, representing 1.54% of its reported portfolio and ranking #11.

Has LMCG INVESTMENTS, LLC been buying or selling REGN?

In the latest 13F filing (Q3 2026), LMCG INVESTMENTS, LLC increased its position in REGN. The position peaked in Q4 2025 at 39.82K shares.

Which other funds hold REGN?

Other major institutional holders of REGN include Dodge & Cox, DODGE & COX, Franklin Resources, among 29 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.